Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
0.6001
-0.0712 (-10.61%)
Mar 26, 2026, 4:00 PM EDT - Market closed
Cytosorbents Revenue
In the year 2025, Cytosorbents had annual revenue of $37.06M with 4.13% growth. Cytosorbents had revenue of $9.23M in the quarter ending December 31, 2025, with 0.92% growth.
Revenue (ttm)
$37.06M
Revenue Growth
+4.13%
P/S Ratio
1.02
Revenue / Employee
$248,745
Employees
149
Market Cap
37.69M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 37.06M | 1.47M | 4.13% |
| Dec 31, 2024 | 35.59M | 4.51M | 14.51% |
| Dec 31, 2023 | 31.08M | -3.60M | -10.39% |
| Dec 31, 2022 | 34.69M | -8.48M | -19.64% |
| Dec 31, 2021 | 43.17M | 2.16M | 5.27% |
| Dec 31, 2020 | 41.00M | 16.06M | 64.35% |
| Dec 31, 2019 | 24.95M | 2.45M | 10.87% |
| Dec 31, 2018 | 22.50M | 7.35M | 48.53% |
| Dec 31, 2017 | 15.15M | 5.62M | 59.02% |
| Dec 31, 2016 | 9.53M | 4.74M | 98.84% |
| Dec 31, 2015 | 4.79M | 668.79K | 16.22% |
| Dec 31, 2014 | 4.12M | 1.70M | 70.18% |
| Dec 31, 2013 | 2.42M | 1.08M | 80.40% |
| Dec 31, 2012 | 1.34M | 1.31M | 3,622.31% |
| Dec 31, 2011 | 36.08K | - | - |
| Dec 31, 2010 | - | - | - |
| Dec 31, 2009 | - | - | - |
| Dec 31, 2008 | - | - | - |
| Dec 31, 2007 | - | - | - |
| Dec 31, 2006 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Accuray | 436.97M |
| Nortech Systems | 116.67M |
| Pulmonx | 90.50M |
| TELA Bio | 80.28M |
| electroCore | 32.03M |
| Spectral AI | 19.65M |
| Elutia | 12.29M |
| NeuroOne Medical Technologies | 11.72M |
CTSO News
- 1 day ago - CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights - PRNewsWire
- 7 days ago - CytoSorbents Announces HotSwap™ Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026 - PRNewsWire
- 21 days ago - CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights - PRNewsWire
- 2 months ago - CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update - PRNewsWire
- 3 months ago - CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025 - PRNewsWire
- 4 months ago - Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London - PRNewsWire
- 4 months ago - CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update - PRNewsWire
- 4 months ago - CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London - PRNewsWire